1233707

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) — FEI 3004835618

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 15, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dresden (Germany)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls